Unilabs announces the closing of agreements to acquire two laboratories in the northern part of Portugal, together with their patient service centres, effective October 1, 2006. Annualized revenues for both laboratories total Euro 3 million.
These two acquisitions will enable Unilabs' Portuguese network to achieve further operating synergies through the establishment of common services to be shared between the laboratories.
Unilabs continues negotiating with other Portuguese laboratories with the objective of reaching by May 2007 annualized revenues of approximately Euro 30 million.
The Unilabs Group (SWX: ULB) is the European leader of clinical testing laboratories. With over 50 laboratories and over 1500 employees operating in 6 countries, Unilabs tests over 3.5 million samples per year using more than 1500 different tests. Unilabs' clinical testing services are used by over 60 public and private hospitals in France, Spain and Switzerland. Unilabs has been listed on the SWX Swiss Stock Exchange since 1997.
Edgard Zwirn, Executive Chairman, is at your disposal for any further query (tel. +41 22 909 77 77). Our press releases are also available on the Internet at our web site www.unilabs.com.
--- End of Message --- WKN: 906648; ISIN: CH0012561640; Index: SPI, SSCI, SBIOM, SLIFE, SPIEX; Listed: Main Market in SWX Swiss Exchange;
Viðskiptablaðið er 25 ára og af því tilefni býðst nýjum áskrifendum að kaupa áskrift á 50% afslætti.
Afmælisverðið er aðeins 2.500 krónur.
Tilboðið er fyrir nýja áskrifendur. Núverandi áskrifendur geta bætt við sig áskrift á þessu verði. Gildir í 4 mánuði. Áskrifendur fá Viðskiptablaðið, Frjálsa verslun og Fiskifréttir sent ásamt vefaðgangi að vb.is og fiskifrettir.is